טוען...
The tellurium‐based immunomodulator, AS101 ameliorates adjuvant‐induced arthritis in rats
Despite undeniable improvement in the management of rheumatoid arthritis (RA), the discovery of more effective, less toxic and, ideally, less immune suppressive drugs are much needed. In the current study, we set to explore the potential anti‐rheumatic activity of the non‐toxic, tellurium‐based immu...
שמור ב:
| הוצא לאור ב: | Clin Exp Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7874835/ https://ncbi.nlm.nih.gov/pubmed/33205391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13553 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|